Rezolve AI is either a breakout “Agentic Commerce” platform on the verge of hypergrowth—or a governance-and-financing trap where guidance can’t be trusted until audited proof arrives.
Overview
Rezolve AI PLC (RZLV) is a UK-based enterprise software company positioned as a controversial, highly volatile AI commerce play. It markets itself as a leader in “Agentic Commerce,” claiming its Brain Suite (Brain Commerce, Brain Checkout, and the brainpowa LLM) can move retailers from keyword search and multi-step checkout to conversational, autonomous shopping and instant conversion—reducing friction and cart abandonment. The company is at an inflection point because its reported historical financials are small, yet management guidance implies extraordinary hypergrowth: at least ~$40M FY2025 revenue, ~ $350M in 2026, and a ~$500M ARR exit run-rate. If true, the stock could be dramatically undervalued on forward multiples; if not, the equity faces severe downside. The narrative is complicated by substantial governance and credibility concerns centered on CEO Daniel Wagner, whose prior company (Powa Technologies) collapsed amid allegations of inflated revenue and non-binding “contracts.” Short sellers argue Rezolve may be repeating similar patterns—overstating ARR via LOIs, generating limited organic AI revenue, and sustaining operations through dilutive Yorkville SEPA financing. The bull case is that Rezolve’s tech and enterprise partnerships (Microsoft/Google) are real, the company is turning profitable (claimed adjusted EBITDA profitability in Dec 2025), and skepticism is creating a mispricing. The bear case is that guidance is unattainable, revenue quality is weak, and toxic financing plus governance could erode shareholder value. The report frames the opportunity as binary: a potential multi-bagger if verified execution occurs, or a capital loss scenario if allegations and financing risks materialize.